•
Dec 31, 2022

REGENXBIO Q4 2022 Earnings Report

Total Revenue
$31.3M
Previous year: $399M
-92.1%
EPS
-$1.38
Previous year: $6.67
-120.7%
Gross Profit
$18.6M
Previous year: $376M
-95.1%
Cash and Equivalents
$97M
Previous year: $345M
-71.9%
Free Cash Flow
-$44.8M
Previous year: $312M
-114.4%
Total Assets
$833M
Previous year: $1.11B
-25.2%

REGENXBIO

REGENXBIO